Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data

被引：0

作者：

Kim A. Papp

Melinda Gooderham

Ignacio Dei-Cas

Adriana LopezTello

Juan C. Garcia-Rodriguez

Carmen Yris Taveras

Azucena Hernández Rousselin

Alberto Lavieri

Mónica Maiolino

Delfina Guadalupe Villanueva Quintero

Lenka Rihakova

Mariano Salibe

Wilfran Pertuz

机构：

[1] K Papp Clinical Research and Probity Medical Research,SKiN Centre for Dermatology and Probity Medical Research

[2] Peterborough and Queen’s University,HIGA Presidente Perón, Servicio de Dermatología, Facultad Medicina UBA

[3] Psoriasis BsAs,undefined

[4] NEKI Servicios Medicos,undefined

[5] Vicente Guerreo,undefined

[6] DermaAdvance Center,undefined

[7] Hospital Regional Universitario Jose Maria Cabral Y Baez,undefined

[8] Hospital Roosevelt,undefined

[9] Calzada Roosevelt,undefined

[10] Private Clinic,undefined

[11] Consultorios Médicos Dr Bouzo,undefined

[12] Grupo Clínico CATEI (Centro de Atención en Enfermedades Inflamatorias) Sociedad Civil,undefined

[13] Novartis Pharmaceuticals Canada Inc.,undefined

[14] Novartis Argentina S.A.,undefined

[15] Novartis Pharma Logistics,undefined

[16] Inc.,undefined

[17] Panama,undefined

来源：

Dermatology and Therapy | 2023年 / 13卷

关键词：

Latin America; Plaque psoriasis; PURE registry; Real-world; Secukinumab;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：269 / 283

页数：14

共 50 条

[1] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
Papp, Kim A.
Gooderham, Melinda
Dei-Cas, Ignacio
LopezTello, Adriana
Garcia-Rodriguez, Juan C.
Taveras, Carmen Yris
Rousselin, Azucena Hernandez
Lavieri, Alberto
Maiolino, Monica
Villanueva Quintero, Delfina Guadalupe
Rihakova, Lenka
Salibe, Mariano
Pertuz, Wilfran
DERMATOLOGY AND THERAPY, 2023, 13 (01) : 269 - 283
[2] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
Papp, Kim A.
Gooderham, Melinda
Dei-Cas, Ignacio
LopezTello, Adriana
Garcia-Rodriguez, Juan C.
Taveras, Carmen Yris
Rousselin, Azucena Hernandez
Lavieri, Alberto
Maiolino, Monica
Quintero, Delfina Guadalupe Villanueva
Rihakova, Lenka
Salibe, Mariano
Pertuz, Wilfran
DERMATOLOGY AND THERAPY, 2022,
[3] Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry
Papp, Kim A.
Gooderham, Melinda
Lynde, Charles
Brassard, Danielle
Al-Mohammedi, Faisal
Prajapati, Vimal H.
Delorme, Isabelle
Albrecht, Lorne
Haydey, Richard
Alam, Maryam Shayesteh
Beecker, Jennifer
Siddha, Sanjay
Maguin, Marie
Farag, Mahmoud S.
Vieira, Antonio
Rihakova, Lenka
Langley, Richard G.
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
[4] Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
Melinda Gooderham
Kim A. Papp
Charles Lynde
Isabelle Delorme
Jennifer Beecker
Lorne Albrecht
Ignacio Dei-Cas
Danielle Brassard
Vimal H. Prajapati
Antonio Vieira
Lenka Rihakova
Dermatology and Therapy, 2023, 13 : 535 - 553
[5] Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
Gooderham, Melinda
Papp, Kim A.
Lynde, Charles
Delorme, Isabelle
Beecker, Jennifer
Albrecht, Lorne
Dei-Cas, Ignacio
Brassard, Danielle
Prajapati, Vimal H.
Vieira, Antonio
Rihakova, Lenka
DERMATOLOGY AND THERAPY, 2023, 13 (02) : 535 - 553
[6] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
Zhou, Jian
Yuan, Yuan
Liu, Yanhua
Chu, Mengyang
Liu, Huan
Liu, Qian
Wang, Rui
Shao, Shuai
Wang, Gang
Yu, Chen
EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
[7] Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study
Schwensen, J. F.
Clemmensen, A.
Sand, C.
Gniadecki, R.
Skov, L.
Zachariae, C.
Iversen, L.
Rasmussen, M.
Thomsen, S. F.
DERMATOLOGIC THERAPY, 2017, 30 (06)
[8] Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis - a real life retrospective study
Galica, Katarzyna
Lesiak, Aleksandra
Ciazynska, Magdalena
Noweta, Marcin
Bednarski, Igor
Narbutt, Joanna
POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 973 - 978
[9] Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
Papp, Kim A.
Gooderham, Melinda
Beecker, Jennifer
Lynde, Charles W.
Delorme, Isabelle
Dei-Cas, Ignacio
Albrecht, Lorne
Rampakakis, Emmanouil
Sampalis, John S.
Vieira, Antonio
Hussein, Shamiza
Chambenoit, Olivier
Rihakova, Lenka
BMC DERMATOLOGY, 2019, 19
[10] Real-world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety
Asawanonda, Pravit
Pattamadilok, Bensachee
Chularojanamontri, Leena
Chuamanochan, Mati
Choonhakarn, Charoen
Chakkavittumrong, Panlop
Sangob, Naruemon
Rajatanavin, Natta
DERMATOLOGIC THERAPY, 2022, 35 (12)

← 1 2 3 4 5 →